Viewing Study NCT04286750


Ignite Creation Date: 2025-12-24 @ 5:05 PM
Ignite Modification Date: 2026-02-25 @ 11:47 PM
Study NCT ID: NCT04286750
Status: COMPLETED
Last Update Posted: 2021-01-20
First Post: 2020-02-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study in Healthy Subjects to Examine the Safety and Tolerability of ACT-1004-1239 Given as Multiple, Gradually Increasing Doses and to Examine the Effects of ACT-1004-1239 on the Body and the Way the Body Takes up, Distributes, and Gets Rid of ACT-1004-1239
Sponsor: Idorsia Pharmaceuticals Ltd.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: ID-086-102
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators